search
Sackler family
Attorneys Linda Singer and Mark Lanier hug outside the US Federal courthouse, Oct. 21, 2019, in Cleveland (AP Photo/Tony Dejak)
October 21, 2019, 4:50 pm
4 drug firms, including Israel’s Teva, reach deal to settle US opioid lawsuit
$260 million agreement comes hours ahead of federal trial over allegations that distributors failed to stop suspicious orders of drugs from being shipped despite warnings of misuse
By AP
In this September 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Connecticut. (AP Photo/Frank Franklin II, File)
October 6, 2019, 7:31 am
Purdue opioid deal blasted as records show $13b. to Sacklers
Many local governments suing pharmaceutical giant over role in opioid crisis say settlement offer doesn’t hold owners accountable for over 400,000 overdose deaths
By GEOFF MULVIHILL
The Sackler Health and Sciences complex at Tel Aviv University. (screen capture: Google Street View)
October 3, 2019, 9:09 pm
From Tel Aviv to Oxford, schools took in millions from OxyContin maker
Sackler family, whose company Purdue Pharma has been blamed in opioid epidemic, gave over $60 million to universities around the world, donations now seen as blood money by some
By Collin Binkley and JENNIFER McDERMOTT
This May 8, 2007, photo shows the Purdue Pharma logo at its offices in Stamford, Connecticut. (AP Photo/Douglas Healey, File)
October 3, 2019, 3:07 pm
Cities push opioid lawsuits against Sackler family, owners of Purdue
Sacklers and their pharmaceutical firm, facing thousands of state and federal cases, are attempting to reach settlement in bankruptcy court
By GEOFF MULVIHILL
In this photo from August 17, 2018, family and friends who have lost loved ones to OxyContin and opioid overdoses leave pill bottles in protest outside the headquarters of Purdue Pharma, which is owned by the Sackler family, in Stamford, Connecticut. (AP Photo/Jessica Hill, File)
September 19, 2019, 2:32 pm
Purdue Pharma asks judge to stop lawsuits against Sacklers
Attorneys for owners of company at center of national opioid crisis say dealing with flow of fresh legal papers diverts resources from actually reaching a settlement
By GEOFF MULVIHILL
Cheryl Juaire, center, of Marlborough, Mass, leads protesters near the Arthur M. Sackler Museum at Harvard University, Friday, April 12, 2019, in Cambridge, Massachusetts.(AP Photo/Josh Reynolds)
September 18, 2019, 12:26 pm
Sackler money, tied to opioid crisis, complicates donation policies for museums
Purdue Pharma legal battle heightens debate over how much nonprofits should rely on the rich, and whether conditions should be imposed on their gifts
By Hillel Italie
Family and friends who have lost loved ones to OxyContin and opioid overdoses protest outside Purdue Pharma headquarters in Stamford, Connecticut, August 17, 2018. (Jessica Hill/AP)
September 16, 2019, 8:02 am
Sackler family’s Purdue Pharma files for bankruptcy as part of opiod settlement
Expected filing comes after pharmaceutical company reaches tentative deal with thousands of local governments and more than 20 states, which could be worth up to $12 billion
By GEOFF MULVIHILL
In this photo from August 17, 2018, family and friends who have lost loved ones to OxyContin and opioid overdoses leave pill bottles in protest outside the headquarters of Purdue Pharma, which is owned by the Sackler family, in Stamford, Connecticut. (AP Photo/Jessica Hill, File)
September 14, 2019, 5:37 pm
NY finds $1 billion in hidden transfers by Sackler family behind OxyContin
Spokesman for Mortimer D.A. Sackler says disclosure by attorney general meant to ‘torpedo a mutually beneficial settlement’ over Purdue Pharma’s alleged pushing of painkillers
By ADAM GELLER
This May 8, 2007, photo shows the Purdue Pharma logo at its offices in Stamford, Connecticut. (AP Photo/Douglas Healey, File)
September 13, 2019, 8:25 am
What a Purdue Pharma bankruptcy means for the Sacklers
As part of a court settlement being negotiated with US, wealthy family would give up control of drugmaker accused of fueling opioid crisis
By SARAH SKIDMORE SELL, GEOFF MULVIHILL and ADAM GELLER
In this August 17, 2018, photo, Christine Gagnon of Southington, Connecticut., protests with other family and friends who have lost loved ones to OxyContin and opioid overdoses at Purdue Pharma LLP headquarters in Stamford, Connecticut (AP Photo/Jessica Hill, File)
September 12, 2019, 1:01 pm
Sackler family and Purdue Pharma to pay billions to settle opioid lawsuits
Tentative agreement reached with thousands of local governments and more than 20 states, could be worth up to $12 billion over time
By GEOFF MULVIHILL and Dave Collins
In this August 17, 2018, photo, Christine Gagnon of Southington, Connecticut., protests with other family and friends who have lost loved ones to OxyContin and opioid overdoses at Purdue Pharma LLP headquarters in Stamford, Connecticut (AP Photo/Jessica Hill, File)
September 9, 2019, 6:00 am
Purdue Pharma says settlement talks in opioid cases not over
Sackler-owned company has threatened bankruptcy, which could complicate efforts by states and victims to get compensation
By GEOFF MULVIHILL
Family and friends who have lost loved ones to OxyContin and opioid overdoses protest outside Purdue Pharma headquarters in Stamford, Connecticut, August 17, 2018. (Jessica Hill/AP)
September 8, 2019, 5:55 am
Bankruptcy likely for Sackler pharma firm Purdue as opioid settlement talks fail
Family refuses to offer counter-proposal, expected to seek protection from courts as lawsuit against maker of addictive painkiller set to go ahead
By GEOFF MULVIHILL and Mark Gillispie
A gate protects the entrance of the Rooksnest estate near Lambourn, England, Tuesday, Aug. 6, 2019. The manor is the domain of Theresa Sackler, widow of one of Purdue Pharma’s founders and, until 2018, a member of the company’s board of directors. A complex web of companies and trusts are controlled by the family, and an examination reveals links between far-flung holdings, far removed from the opioid manufacturer’s headquarters in Stamford, Conn. (AP Photo/Frank Augstein)
September 2, 2019, 6:20 am
Where did the Sacklers move cash from their opioid maker?
Family accused of playing a key role in triggering US opioid epidemic in talks over huge settlement, but much of its money is hidden in a web of companies and trusts
By ADAM GELLER
This February 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy, in Montpelier, Vermont. (AP Photo/Toby Talbot, File)
August 29, 2019, 4:16 am
Sackler family in talks to end ownership of Purdue Pharma in opioid settlement
Company accused of aggressively marketing powerful and addictive painkiller even as it became clear drug wasn’t as safe as advertised; settlement said worth $12 billion
By JTA
The Louvre courtyard and pyramid. (Wikipedia/Alvesgaspar/CC BY-SA)
July 17, 2019, 11:06 pm
Louvre museum removes Sackler name amid opioid controversy
Billionaire family are owners of Purdue Pharma, whose painkiller OxyContin is subject of over 1,000 lawsuits for role in US addiction crisis
By AFP
Load More
Join us!
A message from the Editor of Times of Israel
David Horovitz

The Times of Israel covers one of the most complicated, and contentious, parts of the world. Determined to keep readers fully informed and enable them to form and flesh out their own opinions, The Times of Israel has gradually established itself as the leading source of independent and fair-minded journalism on Israel, the region and the Jewish world.

We've achieved this by investing ever-greater resources in our journalism while keeping all of the content on our site free.

Unlike many other news sites, we have not put up a paywall. But we would like to invite readers who can afford to do so, and for whom The Times of Israel has become important, to help support our journalism by joining The Times of Israel Community. Join now and for as little as $6 a month you can both help ensure our ongoing investment in quality journalism, and enjoy special status and benefits as a Times of Israel Community member.

Become a member of The Times of Israel Community